About DELFI Diagnostics, Inc.
Saving lives through early cancer detection
- Industry
- Medical and Diagnostic Laboratories
- Company size
- 51-200 employees
- Headquarters
- Palo Alto, California
- Founded
- 2019
- Company type
- Privately Held
- Company profile name
- DELFI Diagnostics
DELFI uses AI, machine learning and whole genome sequencing to sensitively detect unique patterns of DNA fragmentation in the blood of patients with cancer.
Specialties
- Biotechnology
- Clinical Trials
- Clinical Research
- Cancer Screening
- Monitoring Research
- Laboratory-Developed Tests
- Liquid Biopsy Tests
- and AI and Machine Learning
Company locations
1810 Embarcadero Rd, Palo Alto, California 94303, US
Locations listed on the company profile. These may include offices outside the United States, and not every location is hiring.
Business areas
- Health Diagnostics
- Health Care
- Biotechnology
- Medical
- Artificial Intelligence (AI)
On LinkedIn
- Followers
- 19,861
- People linked to this company
- 158
People who list this company on LinkedIn, not a verified employee count. Figures reflect the saved company profile.
Funding raised
364,833,315 USD
Total reported by Crunchbase, in US dollars. This is funding raised, not company revenue or valuation.
Explore the company
Employer category
Other employer
Estimated from the company profile. This category has not been confirmed by the employer.